Immunology of COVID‐19 and disease‐modifying therapies: The good, the bad and the unknown
Abstract
The outbreak of the SARS-CoV-2 pandemic, caused by a previously unknown infectious agent, posed unprecedented challenges to healthcare systems and unmasked their vulnerability and limitations worldwide. Patients with long-term immunomodulatory/suppressive therapies, as well as their physicians, were and are concerned about balancing the risk of infection and effects of disease-modifying therapy. Over the last few months, knowledge regarding...
Paper Details
Title
Immunology of COVID‐19 and disease‐modifying therapies: The good, the bad and the unknown
Published Date
Nov 8, 2020
Volume
28
Issue
10
Pages
3503 - 3516
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History